Program

Registration

Welcome by Congress President Kirsi Kuismanen (FI)

Chair: Kristin Jonsdottir (IS)
Bladder fibrosis: causes and consequences (40 min)
Marcus Drake (UK)
Discussion (10 min)

Coffee break in exhibition area

Chair: Rune Svenningsen (NO)
Consequences of oncological treatments on pelvic floor dysfunction
Anterior enteroceles after radical surgery for cancer (35 min)
Ingrid Vollöyhaug (NO)

Radical cystectomy for bladder cancer (35 min)
Eirik Kjøbli (NO)

Discussion (10 min)

Coffee break in exhibition area

Chairs: Mette Hornum Bing (DK) + Riffat Cheema (SE)
Dissertations (a´ 10 min + 5 min discussion)

Tension-free vaginal tape and polyacrylamide hydrogel in treatment of female stress urinary incontinence – a randomized clinical trial
Anna-Maija Itkonen Freitas (FI)

Mid-urethral sling surgery: cure rates, complications and sexual function 10 and 20 years post surgery
Berit Rein Solhaug (NO)

Chairs: Mette Hornum Bing (DK) + Riffat Cheema (SE)
Abstracts (a’ 5 min + 3 min discussion)

ID 34 Mid-urethral sling surgery with polypropylene and long-term malignancy development
Guro Kristine Bårnes (NO)

ID 36 Predictors for treatment failure after polyacrylamide hydrogel (Bulkamid™) injections.
Martin Sommer (NO)

ID 39 A Nordic Perspective on Female Stress Urinary Incontinence Care: Lessons for Shared Clinical Practice
Eeva Linna (FI)

Standing lunch in exhibition area
Lunch meeting for the Nordic Urogynecology Registries (special invite only)

Lunch symposium by Gold Sponsor Plus Pierre Fabre (45 min)
Speaker: To be announced

Chairs: Rune Svenningsen (NO) and Kristin Jonsdottir (IS)
Dissertation (a´ 10 + 5 min)

Intravesical onabotulinumtoxin A treatment in women with overactive bladder - Optimization of anesthesia and assessment of adverse effects.
Meryam El Issaoui (DK)

Chairs: Rune Svenningsen (NO) and Kristin Jonsdottir (IS)
Abstracts (a´ 5 + 3 min)

ID 21 Initial experience of Laparoscopic Pectopexy and Colporrhaphies in Finland.
Anneli Linnamägi (FI)

ID 25 Preliminary results of a multicenter randomized clinical trial for laparoscopic repair of pelvic organ prolapse: Sacropexy vs laparoscopic lateral suspension.
Isabel Ñíguez-Sevilla (ESP)

ID 24 Hysteropexy using laparoscopic lateral suspension for the treatment of pelvic organ prolapse, according to DELPHI consensus of experts.
Isabel Ñíguez-Sevilla (ESP)

ID 32 Association between severity of obstetric perineal tears and risk of levator ani avulsion – a systematic review
Line Norring Holst (DK)

ID 23 Age-related long-term effects of vaginal delivery, pregnancy, and sphincter injury on anal continence: a matched cohort study
Ida Nilsson (SE)

ID 31 Does the delivery method influence sexual activity decades later? A 30 year follow-up
Martina Belluardo (NO)

ID 22 Association of body composition with the symptoms of pelvic floor disorders in middle-aged women: A longitudinal study
Mari Kuutti (FI)

Coffee break in exhibition area

Chairs: Mette Hornum Bing (DK) and Riffat Cheema (SE)
The role of delivery method to the pelvic floor
Assisted vaginal delivery - risk on levator avulsions, risk on sphincters, risk on prolapse, risk of incontinence, scientific evidence (30 min)
Ingrid Vollöyhaug (NO)

Persistent anal incontinence after OASIS (30 min)
Ursula Aho Fält (SE)

Chair: Kirsi Kuismanen (FI)
Pelvic pain (20 min)
Jenny Backlin (SE)

History of NUGA (10 min)
Antti Valpas (FI)

Dinner at the venue. Dress code: Casual
Sign up through the registration site

Registration

Morning symposium by Gold sponsor GE Healthcare (30 min)

Chair: Kristin Jonsdottir (IS)
How your microbiota may impact OAB symptoms and recurrent UTIs (30 min)
Louise Thomsen Schmidt Arenholt (DK)

Tips and tricks for sling operations - How to keep your success rate high and complications low? (30 min)
Knut Hordnes (NO)

Coffee break in exhibition area

Chairs: Mette Hornum Bing (DK) and Riffat Cheema (SE)

Pelvic floor trauma after childbirth – Risk factors, surgical treatment and prevention
Jennie Larsudd-Kåverud (SE)

Second-degree perineal tears – Classification, risk factors, and consequences.
Marthe Dalevoll Macedo (NO)

ID 33 Women’s experiences of perineal wound dehiscence of a second-degree perineal tear and choice of treatment in Denmark: A qualitative interview study
Lærke Vinberg Moestrup (DK)

ID 29 Risk factors associated with perineal wound dehiscence following vaginal delivery
Denise Golmann (SE)

ID 26 Levator ani injury after second-degree perineal tears and episiotomy: associations with symptoms and objective findings 9–12 months postpartum.
Kathrine Perslev (DK)

5 min break

Chairs: Rune Svenningsen (NO) and Kristin Jonsdottir (IS)
Conservative treatment of pelvic organ prolapse
Pessaries (15 min)
Berit Sejer Larsen (DK)

POP and pelvic floor exercise (20 min)
Ulla Due (DK)

Discussion (10 min)

Treatment options for recurrent anterior prolapse (30 min)
Kirsi Kuismanen (FI)

ID 35 Anterior/apical transvaginal mesh repair for recurrent or advanced pelvic organ prolapse: Perioperative safety and short-term subjective outcome.
Speaker: To be announced

ID 38 Pelvic floor dysfunction after a second-degree perineal tear and the impact of residual perineal body thickness - a historical cohort.
Niklas Rexelius (SE)

Digital Health Education Gynecological Well-Being: The Dr. Happy Vagina Initiative by Urogynecologist
Ida Bergman (SE)

Standing lunch in exhibition area
Lunch symposium

Chairs: Kristin Jonsdottir (IS) and Riffat Cheema (SE)

Clinical evaluation after incontinence surgery and dehisced perineal tears: effects on women's pelvic floor health
Anna Lundmark Drca (SE)

Pelvic floor symptoms in women undergoing pelvic organ prolapse surgery.
Päivi Karjalainen (FI)

ID 28 Long-Term Sexual Function After Vaginal Vault Prolapse Surgery: Influence of Surgical Method
Dorte Teilmann-Jørgensen (DK)

ID 37 Is Vaginal Estrogen Treatment Associated with Risk of Thrombosis in Postmenopausal Women? - A Scoping Review
Sofie Lindman Juul (DK)

ID 27 The REPAIR Study: Effect of Prophylactic Antibiotics on Wound Complications and Their Association with One-Year Symptoms
Kathrine Perslev (DK)

ID 30 In vitro and in vivo regenerative potential of ascorbic acid 2-phosphate -releasing poly-L-lactide-co-epsilon-caprolactone: focusing on pelvic organ prolapse applications
Reetta Sartoneva (FI)

Chair: Kirsi Kuismanen (FI)
“Manchester City or Manchester United?”
The Manchester Procedure, two or three compartments?
Video on anterior and mid compartment (25 min)
Niels Klarskov (DK)

Rationale on adding the (kolpo)perineorraphy, video (25 min)
Sissel Oversand (NO)

Discussion (10 min)

Coffee break in exhibition area

Chair: Kirsi Kuismanen (FI)
Urological consequences of urogynecological operations (30 min)
Joergen Bjerregaard (DK) (online)
Discussion (10 min)

Closing and NUGA Awards